Phase I Clinical Trial of 68Ga-NOTA-SNA002
NCT05989997
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
17
Enrollment
INDUSTRY
Sponsor class
Conditions
Solid Tumor
Positron-Emission Tomography(PET)
Interventions
DRUG:
68Ga-NOTA-SNA002
Sponsor
SmartNuclide Biopharma